Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michela Maria Bellocchia (Turin, Italy), Michela Maria Bellocchia, Renza Ambrosanio, Filippo Patrucco, Giulia Verri, Lorena Mercante, Monica Boita, Giuseppe Tabbbia, Alessio Mattei, Paolo Solidoro, Caterina Bucca. Omalizumab, airway obstruction and remodeling. Eur Respir J 2016; 48: Suppl. 60, 4901

Member's Comments

No comment yet.

Related content which might interest you: Airway remodelling in the U-BIOPRED severe asthma cohort Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Airway remodeling and eosinophilic asthma Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Airway hyperresponsiveness (AHR) of small airways assessed by impulse oscillation (IOS) in adult asthma Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Syk mediates airway hyper-responsiveness and airway remodeling in a chronic mouse model of house dust mite induced allergic airways disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Risk factors for airway remodeling and irreversible airway obstruction in Asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Small airway abnormalities in elderly asthmatics with fixed airflow obstruction vs. COPD: High-resolution CT and pulmonary functions Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 The effect of oligomeric proanthocyanidin on airway microenvironment in asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 The effect of inhaled ciclesonide on airway blood flow Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Association between airway inflammation, airway remodelling and physiological changes in asthma Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Association between cardio-ankle vascular index (CAVI) and chronic airway obstruction in asthma Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Can forced oscillation technique parameters predict airway hyperresponsiveness to histamine? Source: International Congress 2014 – Asthma: clinical problems Year: 2014